HUP0201301A3 - Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds - Google Patents

Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds

Info

Publication number
HUP0201301A3
HUP0201301A3 HU0201301A HUP0201301A HUP0201301A3 HU P0201301 A3 HUP0201301 A3 HU P0201301A3 HU 0201301 A HU0201301 A HU 0201301A HU P0201301 A HUP0201301 A HU P0201301A HU P0201301 A3 HUP0201301 A3 HU P0201301A3
Authority
HU
Hungary
Prior art keywords
octan
polymorphs
compounds
preparation
pharmaceutical compositions
Prior art date
Application number
HU0201301A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HUP0201301A2 publication Critical patent/HUP0201301A2/hu
Publication of HUP0201301A3 publication Critical patent/HUP0201301A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0201301A 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds HUP0201301A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (2)

Publication Number Publication Date
HUP0201301A2 HUP0201301A2 (en) 2002-08-28
HUP0201301A3 true HUP0201301A3 (en) 2002-10-28

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201301A HUP0201301A3 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds

Country Status (49)

Country Link
US (1) US6255320B1 (hu)
EP (1) EP1181290B1 (hu)
JP (1) JP3830816B2 (hu)
KR (1) KR100476606B1 (hu)
CN (1) CN1146565C (hu)
AP (1) AP2001002349A0 (hu)
AR (1) AR033331A1 (hu)
AT (1) ATE244239T1 (hu)
AU (1) AU767334B2 (hu)
BG (1) BG65240B1 (hu)
BR (1) BR0011094A (hu)
CA (1) CA2372238C (hu)
CO (1) CO5170463A1 (hu)
CY (1) CY2007011I1 (hu)
CZ (1) CZ295819B6 (hu)
DE (1) DE60003679T2 (hu)
DK (1) DK1181290T3 (hu)
DZ (1) DZ3050A1 (hu)
EA (1) EA003731B1 (hu)
EC (1) ECSP003508A (hu)
EE (1) EE200100656A (hu)
ES (1) ES2199825T3 (hu)
GT (1) GT200000087A (hu)
HK (1) HK1046284A1 (hu)
HN (1) HN2000000077A (hu)
HR (1) HRP20010904A2 (hu)
HU (1) HUP0201301A3 (hu)
IL (1) IL146406A0 (hu)
MA (1) MA26742A1 (hu)
MX (1) MXPA01012325A (hu)
MY (1) MY133508A (hu)
NO (1) NO20015848L (hu)
NZ (1) NZ515349A (hu)
OA (1) OA11956A (hu)
PA (1) PA8496101A1 (hu)
PE (1) PE20010209A1 (hu)
PL (1) PL196046B1 (hu)
PT (1) PT1181290E (hu)
SI (1) SI1181290T1 (hu)
SK (1) SK285820B6 (hu)
SV (1) SV2001000093A (hu)
TN (1) TNSN00120A1 (hu)
TR (1) TR200103473T2 (hu)
TW (1) TWI285204B (hu)
UA (1) UA66925C2 (hu)
UY (1) UY26176A1 (hu)
WO (1) WO2000073304A1 (hu)
YU (1) YU81101A (hu)
ZA (1) ZA200109775B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT1713504T (lt) * 2004-01-30 2017-09-11 Zoetis Services Llc Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
BRPI0507325A (pt) * 2004-01-30 2007-07-03 Pfizer Prod Inc antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
PL1713801T3 (pl) * 2004-02-02 2008-04-30 Pfizer Products Incorporated Sposób wytwarzania 1-(2S,3S)-2-benzhydrylo-N-(5-tert-butylo-2-metoksybenzylo)chinuklidyno-3-aminy
WO2014144894A1 (en) * 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807867A (en) * 1991-05-31 1998-09-15 Pfizer Inc. Quinuclidine derivatives
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
IL146406A0 (en) 2002-07-25
MXPA01012325A (es) 2002-07-22
SI1181290T1 (en) 2003-12-31
UA66925C2 (uk) 2004-06-15
ATE244239T1 (de) 2003-07-15
GT200000087A (es) 2001-11-22
TWI285204B (en) 2007-08-11
DK1181290T3 (da) 2003-09-29
JP2003501354A (ja) 2003-01-14
UY26176A1 (es) 2000-12-29
AU4424800A (en) 2000-12-18
CY2007011I2 (el) 2010-07-28
HUP0201301A2 (en) 2002-08-28
CA2372238C (en) 2006-12-19
EP1181290A1 (en) 2002-02-27
TR200103473T2 (tr) 2002-04-22
EA003731B1 (ru) 2003-08-28
ES2199825T3 (es) 2004-03-01
DE60003679T2 (de) 2004-05-27
CA2372238A1 (en) 2000-12-07
HK1046284A1 (en) 2003-01-03
PA8496101A1 (es) 2002-07-30
NZ515349A (en) 2004-03-26
OA11956A (en) 2006-04-13
WO2000073304A1 (en) 2000-12-07
NO20015848L (no) 2001-12-18
PL196046B1 (pl) 2007-11-30
MY133508A (en) 2007-11-30
SK285820B6 (sk) 2007-09-06
EP1181290B1 (en) 2003-07-02
CY2007011I1 (el) 2010-07-28
CN1146565C (zh) 2004-04-21
PL352716A1 (en) 2003-09-08
DE60003679D1 (de) 2003-08-07
AR033331A1 (es) 2003-12-17
BG65240B1 (bg) 2007-09-28
YU81101A (sh) 2004-07-15
EA200101108A1 (ru) 2002-04-25
CO5170463A1 (es) 2002-06-27
MA26742A1 (fr) 2004-12-20
BG106204A (en) 2002-07-31
KR100476606B1 (ko) 2005-03-18
TNSN00120A1 (fr) 2005-11-10
ZA200109775B (en) 2002-11-28
US6255320B1 (en) 2001-07-03
DZ3050A1 (fr) 2004-03-27
CZ20014269A3 (cs) 2002-04-17
ECSP003508A (es) 2002-02-25
AP2001002349A0 (en) 2001-12-31
PT1181290E (pt) 2003-09-30
CN1353711A (zh) 2002-06-12
SV2001000093A (es) 2001-11-08
HRP20010904A2 (en) 2003-02-28
PE20010209A1 (es) 2001-03-01
HN2000000077A (es) 2001-02-02
BR0011094A (pt) 2002-03-19
JP3830816B2 (ja) 2006-10-11
NO20015848D0 (no) 2001-11-30
EE200100656A (et) 2003-02-17
KR20020010688A (ko) 2002-02-04
CZ295819B6 (cs) 2005-11-16
AU767334B2 (en) 2003-11-06
SK17332001A3 (sk) 2002-07-02

Similar Documents

Publication Publication Date Title
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP9903377A3 (en) The mesylate salt of a macrocyclic bis-indolyl-maleimide derivative, process for its preparation, use thereof and pharmaceutical compositions containing the compound
HUP0200076A3 (en) C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUT72448A (en) O-, n- ors-containing heterobicyclic compounds, pharmaceutical compositions comprising them and process for their preparation
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0101043A3 (en) Controlled release oral dosage form containing [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl]acetonitrile monohydrochlorid and process for its preparation
HUP0200669A3 (en) Process for producing pharmaceutical preparation for oral administration containing tolperison
HUP0001961A3 (en) Substituted dimeric compounds, a process for their preparation and pharmaceutical compositions contaning them
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
HUP0203471A3 (en) Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use
EG22344A (en) Process for preparing of novel pharmaceutical composition
HUP0201301A2 (en) Polymorphs of a crystalline azabicyclo(2,2,2)octan-3-amine citrate and their pharmaceutical compositions and process for preparation of the compounds
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
HUP0201694A3 (en) Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-iso-propyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists, process for their preparation pharmaceutical composition comprising thereof and their use
HUP0004573A3 (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0001712A2 (en) 2,3-methano-amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
HUP0002277A3 (en) Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0000982A3 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HUP0004543A3 (en) Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them
HUP0202106A2 (en) Thienopyranecarboxamide derivatives, process for the preparation thereof, pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees